chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pancreatic disorder, Pancreatitis acute, Pancreatitis necrotising, Ultrasound biliary tract
Clinical narrative: Patient presents to the ED on 12/30/2021 with a Chief Complaint of Abdominal Pain after receiving first dose of vaccine 12/22/2021
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline. No Clinical concerns were reported
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 17 year old patient was given Moderna covid-19 vaccine rather than Pfizer. This was her first in the series. Patient was monitored for 15 minutes post-administration and experienced no adverse effects.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Deafness unilateral
Clinical narrative: Loss of hearing in ear on the same side as injection site.
Age: 87.0
Sex: U
Vaccine: COVID19
Symptoms: Illness, Mental status changes
Clinical narrative: Altered mental status starting day of illness, admitted to hospital for further treatment and care.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Hypoxia, Pneumonia
Clinical narrative: Patient was admitted on 01/29/2022 for Acute respiratory failure and hypoxia and pneumonia due to COVID-19. This is considered a breakthrough case
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Urinary incontinence
Clinical narrative: PATIENT RECEIVED SHOT AND DURING HIS 15 MINUTE WAIT TIME, HE SAID HIS BODY FELT VERY RELAXED AND HE URINATED ON HIMSELF. HE SAID THIS HAS HAPPENED IN THE PAST WHEN RECEIVING SHOTS AND STATES HE DOES FEEL UNEASY AROUND NEEDLES.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Blood disorder, Thrombosis
Clinical narrative: Systemic: Blood Disorder  (diagnosed by MD)-Severe, Additional Details: wife of patient states 2 weeks after covid vaccine pt had blood clots all over his body and was hospitalized.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Patient presents cramps in the face, hands and legs.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pfizer COVID Booster was administered, the expiration "time" on the vial was 2400 02/01/2022 the dose administered at 0900 on 02/02/2022. Phoned Pfizer manufacturer, if stored properly the vial is actually good for 24 hours after puncture. This vial was stored properly and the dose given within 254 hours. Revaccination was not advised. The patient was notified reports filed
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Nausea, Oropharyngeal discomfort, Somnolence, Throat tightness
Clinical narrative: 18 yo female received her vaccine booster of Pfizer Covid19 Vaccination (LOT # FK9896 EXP: 03/2022) on 2/01/2022 around 3:35 PM. Patient reported no allergies, no current medications, and had a meal today before her vaccine booster. Patient reported at 3:35 PM that she had chest pressure and feeling drowsy and placed in a gravity chair during observation. Patient reported that similar symptoms occurred her first and second doses of Pfizer and did 30 minutes of observation her second dose of Pfizer. At 3:35 BP of 140/82, HR 55, and 02 of 100 RA and Respirations 16. At 3:45 Patient reported "feeling drowsy, chest pressure, and a little nauseas". At 3:42  Patients Vital Signs: BP of 130/72 , HR 55, and 02 of 98% RA. At 3:52 PM patient reported feeling "pressure around her chest and tightness in her throat. At 4:03 PM Patient was reevaluated and reported " No nausea, no chest pressure, and slight throat pressure with no troubles breathing". At 4:07 Patients Vital Signs: BP 128/76, 02 of 99% on RA, and HR of 52. At 4:10 PM the patient reported " no pressure on throat or chest pressure" and at 4:15 PM reported " no more pressure". At 4:13 PM BP was 132/76, O2 of 98% on R, and HR of 55. At 4:20 the Patient was informed and educated by Vaccine Site Co-Lead RN to monitor for common side effects to such as muscle soreness and fatigue and to Call 911 or go to nearest emergency room if any severe adverse reactions occur such as shortness of breath, chest pressure, throat closing, and generalized rash. At 4:20 Patient left observation with no reports of chest pressure, nausea, drowsiness, and throat tightness.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given 0.5ml instead of 0.25ml patient has had no problems since vaccination and was sent a letter informed of dosage given
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED AN EXPIRED DOSE OF THE PFIZER VACCINE.  PER STORAGE INSTRUCTIONS, THE VACCINE SHOULD HAVE BEEN WASTED ON 01.21.22.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac failure, Cardiac failure congestive, Chest X-ray, Dizziness
Clinical narrative: 4 days after shot started to feel slurred speech, fatigue, 'sleepy', bilateral drooping of eyelids and right sided jaw/dental pain.  13 days after shot (11/17/21) had admission for CHF/volume overload and new onset Atrial fibrillation.  She had another hospitalization 12/14/21 where she was found to be in heart failure with volume overload and pleural effusions were noted.  She had another hospitalization for acute dizziness and a fall 1/31/22.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Dysarthria, Echocardiogram, Electrocardiogram, Eyelid ptosis, Fall
Clinical narrative: 4 days after shot started to feel slurred speech, fatigue, 'sleepy', bilateral drooping of eyelids and right sided jaw/dental pain.  13 days after shot (11/17/21) had admission for CHF/volume overload and new onset Atrial fibrillation.  She had another hospitalization 12/14/21 where she was found to be in heart failure with volume overload and pleural effusions were noted.  She had another hospitalization for acute dizziness and a fall 1/31/22.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypervolaemia, Laboratory test, Pain in jaw, Pleural effusion
Clinical narrative: 4 days after shot started to feel slurred speech, fatigue, 'sleepy', bilateral drooping of eyelids and right sided jaw/dental pain.  13 days after shot (11/17/21) had admission for CHF/volume overload and new onset Atrial fibrillation.  She had another hospitalization 12/14/21 where she was found to be in heart failure with volume overload and pleural effusions were noted.  She had another hospitalization for acute dizziness and a fall 1/31/22.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Ultrasound Doppler, X-ray
Clinical narrative: 4 days after shot started to feel slurred speech, fatigue, 'sleepy', bilateral drooping of eyelids and right sided jaw/dental pain.  13 days after shot (11/17/21) had admission for CHF/volume overload and new onset Atrial fibrillation.  She had another hospitalization 12/14/21 where she was found to be in heart failure with volume overload and pleural effusions were noted.  She had another hospitalization for acute dizziness and a fall 1/31/22.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Axillary pain, Burning sensation, Erythema, Immediate post-injection reaction
Clinical narrative: immediate medication taste in mouth  about 5:35pm ,bilateral ears itching , burning, painful, skin sloughing 6:00PM,  9:00pm bilateral drainage noted to ears. 1/18/22 grapefruit size mass under left arm with pain and tenderness, chest rash and palms red and itch spastically
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Otorrhoea, Pain, Product after taste, Pruritus, Rash
Clinical narrative: immediate medication taste in mouth  about 5:35pm ,bilateral ears itching , burning, painful, skin sloughing 6:00PM,  9:00pm bilateral drainage noted to ears. 1/18/22 grapefruit size mass under left arm with pain and tenderness, chest rash and palms red and itch spastically
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Skin exfoliation, Tenderness
Clinical narrative: immediate medication taste in mouth  about 5:35pm ,bilateral ears itching , burning, painful, skin sloughing 6:00PM,  9:00pm bilateral drainage noted to ears. 1/18/22 grapefruit size mass under left arm with pain and tenderness, chest rash and palms red and itch spastically
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Rash
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Medium
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Incorrect dose administered, Migraine, Nausea, Product preparation issue
Clinical narrative: Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline. During conversation of being notified of VAERS report she reported experiencing Nausea & vomiting  with a migraine evening after injection. She stated she missed 3 days of work. Reports feeling well now with no clinical concerns
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline. During conversation of being notified of VAERS report she reported experiencing Nausea & vomiting  with a migraine evening after injection. She stated she missed 3 days of work. Reports feeling well now with no clinical concerns
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED AN EXPIRED DOSE OF THE PFIZER VACCINE.  PER STORAGE INSTRUCTIONS, THE VACCINE SHOULD HAVE BEEN WASTED ON 01.21.22.
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Diarrhoea, Dyspnoea, Hypophagia, Nausea
Clinical narrative: Patient is a 65 year old female with a history of AFIB (on Eliquis), COPD, chronic airflow obstruction, a MI, polycystic kidney disease, renal disease, a hysterectomy, a hernia repair, a back surgery, and a renal transplant who presents to the ED with a chief complaint of difficulty breathing that began about 3 days ago. Patient explains that she typically only wears supplemental oxygen at night via CPAP, although about 3 days ago her difficulty breathing and shortness of breath began worsening. She additionally has been experiencing a cough with "clear" phlegm production, as well as decreased oral intake and oliguria. Her PCP recommended that she double her dose of Bumex for the last 3 days, although she feels she has had no improvement with urine output. This morning, she woke up after wearing her CPAP machine at night and noted oxygen saturation values of 77%. Patient additionally complains of nausea, vomiting, and diarrhea for a ?few? days. Due to concerns for her symptoms, a call to EMS was placed to be have patient brought to the ED for evaluation today. Patient adds that she follows with Dr. in pulmonology, and she is compliant with taking her Eliquis. She believes she has been on steroids recently, although she is unsure. Patient denies fever or chills. The patient is a former smoker and has no further complaints at this time.
Age: 64.0
Sex: U
Vaccine: COVID19
Symptoms: Oliguria, Positive airway pressure therapy, Productive cough, Vomiting
Clinical narrative: Patient is a 65 year old female with a history of AFIB (on Eliquis), COPD, chronic airflow obstruction, a MI, polycystic kidney disease, renal disease, a hysterectomy, a hernia repair, a back surgery, and a renal transplant who presents to the ED with a chief complaint of difficulty breathing that began about 3 days ago. Patient explains that she typically only wears supplemental oxygen at night via CPAP, although about 3 days ago her difficulty breathing and shortness of breath began worsening. She additionally has been experiencing a cough with "clear" phlegm production, as well as decreased oral intake and oliguria. Her PCP recommended that she double her dose of Bumex for the last 3 days, although she feels she has had no improvement with urine output. This morning, she woke up after wearing her CPAP machine at night and noted oxygen saturation values of 77%. Patient additionally complains of nausea, vomiting, and diarrhea for a ?few? days. Due to concerns for her symptoms, a call to EMS was placed to be have patient brought to the ED for evaluation today. Patient adds that she follows with Dr. in pulmonology, and she is compliant with taking her Eliquis. She believes she has been on steroids recently, although she is unsure. Patient denies fever or chills. The patient is a former smoker and has no further complaints at this time.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: This nurse removed opened vial of Moderna from storage, 2-8 C. Placed in cooler with ice packs along with two other unopened vials of Moderna. This nurse then transported and gave the three vials to the agency nurse. Agency nurse administered open vial of Moderna to persons who had signed up for the Booster vaccination of the Moderna Vaccination 0.25ml. Once completed updated Manager that the bottle given to her was open and was going to open another vial. This nurse confirmed with the manager that the bottle had been opened previously, 1/19/2022. This nurse had misread the storage information regarding Moderna to be stored unopened and unused for 30 days. This nurse made telephone call to each person affected by this opened vial. Per Medical Director Dr., offered everyone a dose of 0.25ml out of the new unopened vial. RN.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Headache, Ischaemia, Magnetic resonance imaging
Clinical narrative: She got her vaccine, had no reaction immediately other than her arm was a little sore the rest of the day.  The next day her arm was a little sore, perhaps a tiny bit of fatigue.  Went to bed and woke up about 2 or 3:00 AM and her ears were screaming, ringing, and had a weird headache, and was frightened because of the way she felt.  She went to the UC and they gave her Ativan and told her that was having anxiety and sent her home.  The ringing in the ears never stopped, and 2 days later the same thing happened in the middle of the night.  This happened 5 times up until the end of January and all that whole time and up until today she has been woken up 2-3 times a night with ringing in her ears.  She had a MRI done which did not show any fluid or growth/tumor in her ears.  It did show some ischemia, but no reason for the ringing in her ears.  She went to an ENT to find out what was going on, and is in the process to have a hearing test to see if there is something wrong.   She has not slept a full night since the getting the vaccine.  She has to turn the TV on in the night and sit up to calm herself down as it is a horrible, horrible thing.   She said that she was fine until the booster shot.    She only had sore arms from the 1st and 2nd ones, light fatigue but nothing like this.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Sleep disorder, Tinnitus
Clinical narrative: She got her vaccine, had no reaction immediately other than her arm was a little sore the rest of the day.  The next day her arm was a little sore, perhaps a tiny bit of fatigue.  Went to bed and woke up about 2 or 3:00 AM and her ears were screaming, ringing, and had a weird headache, and was frightened because of the way she felt.  She went to the UC and they gave her Ativan and told her that was having anxiety and sent her home.  The ringing in the ears never stopped, and 2 days later the same thing happened in the middle of the night.  This happened 5 times up until the end of January and all that whole time and up until today she has been woken up 2-3 times a night with ringing in her ears.  She had a MRI done which did not show any fluid or growth/tumor in her ears.  It did show some ischemia, but no reason for the ringing in her ears.  She went to an ENT to find out what was going on, and is in the process to have a hearing test to see if there is something wrong.   She has not slept a full night since the getting the vaccine.  She has to turn the TV on in the night and sit up to calm herself down as it is a horrible, horrible thing.   She said that she was fine until the booster shot.    She only had sore arms from the 1st and 2nd ones, light fatigue but nothing like this.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: This  patient was admitted to Hospital on 1/29/222 for COVID related symptoms. This is considered a breakthrough case
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: sore throat, fever, headache, fatigue, SOA admitted to hospital 2/1- placed on 3L O2, started on decadron and remdesivir
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pain, Pain in extremity
Clinical narrative: 30 minutes after the vaccine I experienced painful stinging sensation in both hands and feet. I have had this symptoms everyday since the vaccine up to this current day.  Symptoms are affecting my ability to function as it is very painful.   Pregnant when I took the vaccine- EDD 05/2022.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal dreams, Asthenia, Cough, Dyspnoea, Epistaxis
Clinical narrative: aching, weakness, nosebleeds, fever, chest and nasal  congestion and cough, shortness of breath    hallucination/ strange dreams
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Hallucination, Nasal congestion, Pain, Pyrexia, Respiratory tract congestion
Clinical narrative: aching, weakness, nosebleeds, fever, chest and nasal  congestion and cough, shortness of breath    hallucination/ strange dreams
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Computerised tomogram, Diarrhoea, Echocardiogram, Malaise
Clinical narrative: Development of MIS-C with COVID like symptoms developing on 11/27/21 and MIS-C symptoms (multi system involvement ) beginning on 12/2/21). Respiratory, Gastrointestinal, dermatologic, and neurologic symptoms reported, starting with fever vomiting, diarrhea, rash, and neck stiffness.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Multisystem inflammatory syndrome in children, Musculoskeletal stiffness, Neurological symptom, Pyrexia
Clinical narrative: Development of MIS-C with COVID like symptoms developing on 11/27/21 and MIS-C symptoms (multi system involvement ) beginning on 12/2/21). Respiratory, Gastrointestinal, dermatologic, and neurologic symptoms reported, starting with fever vomiting, diarrhea, rash, and neck stiffness.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Respiratory symptom, SARS-CoV-2 antibody test, Vomiting
Clinical narrative: Development of MIS-C with COVID like symptoms developing on 11/27/21 and MIS-C symptoms (multi system involvement ) beginning on 12/2/21). Respiratory, Gastrointestinal, dermatologic, and neurologic symptoms reported, starting with fever vomiting, diarrhea, rash, and neck stiffness.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED AN EXPIRED DOSE OF THE PFIZER VACCINE.  PER STORAGE INSTRUCTIONS, THE VACCINE SHOULD HAVE BEEN WASTED ON 01.21.22.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blindness unilateral, Facial paralysis, Headache, Heart rate increased
Clinical narrative: After receiving the 2nd dose I had a red and swollen area on my arm around the injection site. A week later I started getting a headache, muscle pains, joint pains, and heart palpitations. My heart rate goes up to 130 or 140 then go back down to my normal resting heart rate. The heart palpitations come and go, on and off. I had an incident in October 2021 where I went to lay down. Then I had a heart palpitation, and it caused partial vison loss in my right eye. My doctor told me to follow up at the ER, but by the time I was going to go to the ER it had passed. When I went to see my doctor he told me I was having some right side facial drooping. I have a referral to see a cardiologist. My heart palpitations usually last for 5 or 10 minutes.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Myalgia, Palpitations
Clinical narrative: After receiving the 2nd dose I had a red and swollen area on my arm around the injection site. A week later I started getting a headache, muscle pains, joint pains, and heart palpitations. My heart rate goes up to 130 or 140 then go back down to my normal resting heart rate. The heart palpitations come and go, on and off. I had an incident in October 2021 where I went to lay down. Then I had a heart palpitation, and it caused partial vison loss in my right eye. My doctor told me to follow up at the ER, but by the time I was going to go to the ER it had passed. When I went to see my doctor he told me I was having some right side facial drooping. I have a referral to see a cardiologist. My heart palpitations usually last for 5 or 10 minutes.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Fever, chills, extreme fatigue, joint pain, headache, and tinnitus. Everything lasted about 5 days except for the tinnitus. The tinnitus varies in severity and is present everyday since the first dose.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Fever, chills, extreme fatigue, joint pain, headache, and tinnitus. Everything lasted about 5 days except for the tinnitus. The tinnitus varies in severity and is present everyday since the first dose.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED AN EXPIRED DOSE OF THE PFIZER VACCINE.  PER STORAGE INSTRUCTIONS, THE VACCINE SHOULD HAVE BEEN WASTED ON 01.21.22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was administered 0.5ml instead of 0.25ml of booster 3rd dosage, letter was sent to patient informing her of dosage given
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cellulitis, Joint swelling, Peripheral swelling, Pruritus, Rash
Clinical narrative: Skin rash on the extremities of the right leg with itching and then an ulcer in the form of cellulitis, swelling in the legs and ankles.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ulcer
Clinical narrative: Skin rash on the extremities of the right leg with itching and then an ulcer in the form of cellulitis, swelling in the legs and ankles.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED AN EXPIRED DOSE OF THE PFIZER VACCINE.  PER STORAGE INSTRUCTIONS, THE VACCINE SHOULD HAVE BEEN WASTED ON 01.21.22.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Vaccine was given to a patient that was not eligible to receive vaccine (Moderna) as patient is 12 y/o. No adverse noted during assessment or reported after visit.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Clinician prepared vial with 1.3ml Normal Saline diluent rather than 1.8ml Normal Saline. No Clinical concerns were reported
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: This nurse removed opened vial of Moderna from storage, 2-8 C. Placed in cooler with ice packs along with two other unopened vials of Moderna. This nurse then transported and gave the three vials to the agency nurse. Agency nurse administered open vial of Moderna to persons who had signed up for the Booster vaccination of the Moderna Vaccination 0.25ml. Once completed updated Manager that the bottle given to her was open and was going to open another vial. This nurse confirmed with the manager that the bottle had been opened previously, 1/19/2022. This nurse had mis read the storage information regarding Moderna to be stored unopened and unused for 30 days. This nurse made telephone call to each person affected by this opened vial. Per Medical Director Dr., offered everyone a dose of 0.25ml out of the new unopened vial. RN
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Feeling abnormal, Injection site pain, Pain
Clinical narrative: Shivers during the night.  Sore arm at injection site and general body aches in the morning.  Mild brain fog until about 1pm the next day.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Hypoaesthesia, Thinking abnormal
Clinical narrative: Numbness to the left shoulder down to the hand. Numbness to the neck. Numbness on the left side of the face. Symptoms started within a few seconds and lasted for several days. Headaches lasted several days. "Brain fog" or "unable to think as normal or quickly" had started several days after first injection and is still current today.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Left axilla lymph node swollen noted the evening of receiving Covid -Moderna vaccine.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cardio-respiratory arrest, Death, Dyspnoea, Endotracheal intubation
Clinical narrative: seen in ED with SOB; diagnosed with COVID pneumonia; treated with antibiotic and steroids; worsening SOB; O2 supplementation in ICU with BiPAP 100% alternated with Vapotherm and NRB adjuncts; was able to be moved to medical floor; later experienced code blue, (likely GI bleed), CPR performed; intubated with mechanical ventilation; transferred to SICU; family chose to not perform additional CPR or other aggressive support if needed; pt's condition worsened; in house hospice was chosen and pt died in the hosp
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal haemorrhage, Intensive care, Mechanical ventilation, Positive airway pressure therapy, Resuscitation
Clinical narrative: seen in ED with SOB; diagnosed with COVID pneumonia; treated with antibiotic and steroids; worsening SOB; O2 supplementation in ICU with BiPAP 100% alternated with Vapotherm and NRB adjuncts; was able to be moved to medical floor; later experienced code blue, (likely GI bleed), CPR performed; intubated with mechanical ventilation; transferred to SICU; family chose to not perform additional CPR or other aggressive support if needed; pt's condition worsened; in house hospice was chosen and pt died in the hosp
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood alkaline phosphatase normal, Blood bilirubin normal, Blood chloride normal
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol normal, Blood creatinine increased, Blood glucose increased, Blood lactic acid, Blood magnesium increased
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea increased, COVID-19, Carbon dioxide normal
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac index, Catheter placement, Catheterisation cardiac, Cerebrovascular accident, Device alarm issue
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Device malfunction, Device related thrombosis, Diuretic therapy, Dyspnoea, Echocardiogram abnormal
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Ejection fraction decreased, Exposure to SARS-CoV-2, Haematocrit normal, Haemoglobin decreased, Hypertension
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertensive emergency, Hypotension, Hypovolaemia, Hypoxia, Illness
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio increased, Left ventricular dilatation, Left ventricular dysfunction, Malaise, Mitral valve incompetence
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Platelet count normal, Pulmonary arterial pressure, Pulmonary arterial pressure abnormal, Pulmonary arterial wedge pressure, Pulmonary oedema
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Right ventricular dilatation, SARS-CoV-2 test positive, Systolic dysfunction, Transient ischaemic attack, Tricuspid valve incompetence
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Ventricular tachycardia, Wall motion score index abnormal, White blood cell count normal
Clinical narrative: 58 Y male with h/o ischemic cardiomyopathy with prior STEMI/NSTEMI, stents to LM/LAD/Lcx, last intervention was LAD IST in 12/2019, s/p HVAD implantation on 7/6/20. Post op course c/w takeback for clot evacuation 7/9/20, ischemic bowel requiring ex lap and colostomy placement 7/18/20, thrombectomy of R external iliac artery and fasciotomy 7/23/20, and PNA.  Post LVAD complications: GIB, DL infection, enterococcus bacteremia on chronic amox.  TIA/CVA, pump thrombosis 7/2021.  Numerous hospital admissions in 2022. 1/2/22-1/6/22 pulmonary edema discharged after diuresis and optimization. 1/12-1/13/22 after +Covid exposure and illness with hypoxemia. Received 2 doses of remdesivir and decadron and during the hospital stay noted hypotension and hypovolemia, antihypertensives were adjusted.  1/19/22-1/22/22 for ongoing SOB, hypoxemia and post Covid symptoms, completed 5 days of remdesivir and decadron. Hypertensive during hospital stay, increase BP meds   Now presented on 1/23/22 with numerous low flow alarms.  High Pis.  Hypertensive. Lactate 2.1  Admitted for hypertensive emergency, nitroglycerin gtt transitioned to nipride gtt.  BP better controlled, uptitrating oral antihypertensives increase amlodipine from 2.5 to 5.  Increase hydral to 75 TID to 100 TID.  Increase isordil to 40 TID and hydral 100TID. Added coreg 3.125mg BID.   COVID+ with hypoxemia dx on 1/12: continue isolation received a total of 5 doses of remdesivir and decadron
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urine present, Chromaturia
Clinical narrative: Two days after the vaccine I started urinating blood that was the color of Coca-Cola. Two days later it stopped.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED AN EXPIRED DOSE OF THE PFIZER VACCINE.  PER STORAGE INSTRUCTIONS, THE VACCINE SHOULD HAVE BEEN WASTED ON 01.21.22.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Computerised tomogram head abnormal, Facial paralysis, Hypoaesthesia, Laboratory test
Clinical narrative: On December 16,2021 had I experienced facial numbness and paralysis. It started with tongue moved to entire side of my face. I went to ER had a CT scan diagnosed with Bells Palsy was prescribed a steroid.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was administered 0.5ml instead of 0.25ml booster 3rd vaccine, a letter was sent to her informing her of dosage given
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Nausea, Pain in extremity
Clinical narrative: Diarrhea Arm pain (mild) Nausea (mild)
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness, Blood bicarbonate decreased, Blood lactic acid increased, Electroencephalogram abnormal, Encephalopathy
Clinical narrative: Pt has history of metabolic disease, MELAS, in which she develops acute flares with headaches, vomiting, seizures, scotomas, and strokes in reaction to specific stressors. Received Pfizer COVID vaccine on 1/21/22. Developed fatigue and decreased oral intake on 1/28, then vision loss and scotomas on  1/30, which she describes as "sparkles" in her vision. No seizures. Because of persistence of symptoms for 3 days without improvement, family brought her to the emergency room for evaluation, and she was admitted to rule out strokes and acute MELAS flare. Symptoms improved with supportive IVF, medications for acute metabolic crisis (arginine, carnitine), and OTC NSAIDs. Discharge date from hospital currently pending, but anticipated 2/3/22. OF NOTE, family reported that after receiving her 2nd dose COVID PFizer vaccine on 6/6/21, pt developed  slurred speech and HAs approximately around 6/17. MRI brain performed on 6/24 demonstrated multiple subacute infarcts consistent with acute MELAS flare, in addition to interval progression of cerebral brain loss related to chronic condition.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypophagia, Metabolic disorder, Ophthalmological examination abnormal, Photopsia
Clinical narrative: Pt has history of metabolic disease, MELAS, in which she develops acute flares with headaches, vomiting, seizures, scotomas, and strokes in reaction to specific stressors. Received Pfizer COVID vaccine on 1/21/22. Developed fatigue and decreased oral intake on 1/28, then vision loss and scotomas on  1/30, which she describes as "sparkles" in her vision. No seizures. Because of persistence of symptoms for 3 days without improvement, family brought her to the emergency room for evaluation, and she was admitted to rule out strokes and acute MELAS flare. Symptoms improved with supportive IVF, medications for acute metabolic crisis (arginine, carnitine), and OTC NSAIDs. Discharge date from hospital currently pending, but anticipated 2/3/22. OF NOTE, family reported that after receiving her 2nd dose COVID PFizer vaccine on 6/6/21, pt developed  slurred speech and HAs approximately around 6/17. MRI brain performed on 6/24 demonstrated multiple subacute infarcts consistent with acute MELAS flare, in addition to interval progression of cerebral brain loss related to chronic condition.